Description
Abemaciclib (LY2835219) is a dual inhibitor of CDK4/6 (IC50=2/10 nM) with selectivity and specificity. Abemaciclib has antitumor activity and is used to treat advanced or metastatic breast cancer.
Molecular Formula
C27H32F2N8
Smiles
C(C)(C)N1C=2C(=C(F)C=C(C2)C3=NC(NC4=CC=C(CN5CCN(CC)CC5)C=N4)=NC=C3F)N=C1C
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
DMSO: 2.17 mg/mL (4.28 mM), Sonication is recommended.Ethanol: 1.69 mg/mL (3.34 mM), Sonication is recommended.10% DMSO+90% Saline: 0.1 mg/mL (0.2 mM), In vivo: Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
Relative Density
1.32 (Predicted)